Safety and Tolerability Study of Liquid Alpha1 Proteinase Inhibitor (API) in Subjects With Cystic Fibrosis

Update Il y a 4 ans
Reference: NCT01347190

Woman and Man

Extract

Study to assess safety and tolerability of a single dose of study-drug administered to Cystic Fibrosis (CF) patients.


Inclusion criteria

  • Cystic fibrosis


Links